Arindam Roy | Authors

What are the characteristics and relevant considerations for the development and validation of a stability-indicating method?

In the pharmaceutical industry, the demonstration of drug substance (DS) or drug product (DP) stability over the shelf life is an important aspect of the regulatory requirements.

A discussion of active pharmaceutical ingredient (API) selection, drug product development, and mass spectrometry instrumentation